Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085707/0/en/Paratek-Pharmaceuticals-Completes-Acquisition-of-Optinose-Creating-an-Expanded-Portfolio-of-Specialty-Therapies.html
16 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/16/3083010/0/en/Paratek-Pharmaceuticals-to-Present-Clinical-Data-on-NUZYRA-omadacycline-at-the-American-Thoracic-Society-ATS-2025-International-Conference.html
10 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/10/3059143/0/en/Paratek-Pharmaceuticals-to-Present-New-Data-on-NUZYRA-omadacycline-at-ESCMID-Global-2025.html
21 Mar 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/paratek-acquires-optinose-and-rhinosinusitis-spray-xhance-330m
15 Nov 2024
// EXPRESSPHARMA
https://www.expresspharma.in/paratek-phase-iib-data-shows-omadacyclines-potential-to-address-unmet-needs-in-ntm-treatment-says-globaldata/
14 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/14/2981251/0/en/Paratek-Pharmaceuticals-Announces-Completion-of-U-S-Onshoring-Program-Making-NUZYRA-omadacycline-the-Only-Novel-Antibiotic-with-Domestic-Supply-and-Manufacturing-Capabilities.html
ABOUT THIS PAGE